The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Economic benefits of adaptive abiraterone therapy for advanced prostate cancer.
 
Neil Thomas Mason
Stock and Other Ownership Interests - Interpares Biomedicine
 
Jason M Burkett
No Relationships to Disclose
 
Ryan Nelson
No Relationships to Disclose
 
Julio M. Pow-Sang
No Relationships to Disclose
 
Robert A Gatenby
No Relationships to Disclose
 
Timothy Edward Kubal
No Relationships to Disclose
 
John Williamson Peabody
Employment - QURE Healthcare
Leadership - QURE Healthcare
Stock and Other Ownership Interests - QURE Healthcare
Research Funding - Aegis Sciences Corporation (Inst); Applied Proteomics (Inst); GlycoMark (Inst); Natera (Inst)
Patents, Royalties, Other Intellectual Property - QURE Healthcare
 
Douglas D. Letson
Consulting or Advisory Role - Stryker
Travel, Accommodations, Expenses - Stryker
 
Howard L. McLeod
Leadership - Cancer Genetics
Stock and Other Ownership Interests - Cancer Genetics; Interpares Biomedicine
Honoraria - Genentech/Roche; Illumina
Consulting or Advisory Role - Admera Health; Cancer Genetics; eviCore healthcare; Gentris; NIH/NCI; Pharmazam; Saladax Biomedical
 
Jingsong Zhang
Honoraria - AstraZeneca/MedImmune; Bayer; Sanofi
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Sanofi
Speakers' Bureau - AstraZeneca/MedImmune; Sanofi
Research Funding - Astellas Medivation (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst)